Industry Updates for the Psychedelics World

Psychedelics News

Industry

1 Mar 2023

Investing in Psychedelic Therapy Real Estate with Healing REIT

We sat down with the team at Healing REIT to discuss the challenges of finding suitable properties for psychedelic therapy and how real estate infrastructure will play a critical role...

By Jason Najum

Industry

28 Feb 2023

Cultivating Psilocybin Consistency: A Deeper Look at Entheogen Biotech

Entheogen Biotech is a Canadian-based research and development biotech company, building an integrated approach towards modern mental health care, with a mushroom production and lab facility in Jamaica....

By Microdose

Industry

23 Feb 2023

Compass Pathways’ New Psilocybin For Depression Trial, Explained

On February 17th, psychedelic medicine company Compass Pathways (Nasdaq: CMPS) registered a new Phase 2 clinical trial attempting to treat Major Depressive Disorder using psilocybin-assisted therapy....

By James Hallifax

Industry

15 Feb 2023

Small Pharma Doses First Patient in DMT Phase I Trial

Small Pharma Doses First Patient in DMT Phase I Trial....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

3 Feb 2023

Terran Biosciences Files Patent for Oral DMT and 5-MeO-DMT

Terran Biosciences announces publication of PCT patent applications covering orally active forms of DMT and 5-MeO-DMT and long-acting MDMA...

By Microdose NewsDesk

Breaking News, Industry

3 Feb 2023

Australia Reschedules Psilocybin and MDMA for Therapeutic Use

Breaking news as Australia is rescheduling psychedelics psilocybin and MDMA for therapeutic use....

By Microdose NewsDesk

Industry

2 Feb 2023

FDA Grants Pharmather Orphan Drug Designation for KETARX (Ketamine)

PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™ (Ketamine) for the Treatment of Rett Syndrome...

By Microdose NewsDesk

Industry

1 Feb 2023

Apex Labs Granted Approval for At-Home Phase 2b Psilocybin Trial

Lesser-known psychedelic firm Apex Labs has announced approval by Health Canada of a Phase 2b trial....

By Jason Najum

Industry

1 Feb 2023

Numinus Receives Approval for Clinical Trial using Psilocybe Cubensis Tea

Numinus Receives Clinical Trial Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea...

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result